Canada's Public Equities Markets

14-15 / 36

CANADA’S PUBLIC EQUITIES MARKETS. YOUR OPPORTUNITY. 15 14
CLEAN TECHNOLOGY AND RENEWABLE ENERGY: over 120 companies listed in this sector
Ballard Power Systems Inc. (TSX focuses on selling technology for commercial uses as such
backup power systems, forklifts and buses. Among its activities, the company sells telecom backup
systems in high-growth markets in Asia and has an agreement to develop fuel cells for use in
powering demonstration cars for Volkswagen.
--> Burnaby, BC
New Flyer Industries Inc. (TSX ) manufactures heavy-duty transit buses in the U.S. and Canada
including drive systems powered by clean diesel, natural gas, diesel-electric hybrid, electric trolley
and battery-electric. With more than 3,000 employees, the company also operates an aftermarket
parts organization to support all types of transit buses including the 32,000 New Flyer and NABI
heavy-duty transit buses currently in operation.
--> Winnipeg, MB
Questor Technology Inc. (TSXV ) is an international clean air technology company active
globally. It develops and sells clean combustion solutions for waste gases. Questor’s combustion
and dispersion models have been approved by the Alberta Energy Utilities Board. The company works
with multinationals such as Exxon/Mobil, Shell, TransCanada Pipelines, Vacquero and Dominion
Exploration. Questor was also included in the ranking.
--> Calgary, AB
LIFE SCIENCES: almost 120 companies to discover in this sector
Immunovaccine Inc.* (TSX ) is a clinical-stage vaccine development company that develops
cancer immunotherapies and infectious disease vaccines based on a patented formulation. The U.S.
National Institute of Health recently asked the company to apply technology from its anthrax vaccine
(DepoVax) to help fight the spread of Ebola.
--> Halifax, NS
Medicure Inc. (TSXV ) is a specialty pharmaceutical company involved in research, clinical
development and commercialization of human therapeutics. The company is focused on a drug
that may reduce the rate of thrombotic cardiovascular events in patients with certain types of acute
coronary conditions.
--> Winnipeg, MB
* Immunovaccine Inc. graduated from TSXV to TSX on 26 November 2014.
Tekmira Pharmaceuticals Corporation (TSX develops drugs in the field of ribonucleic acid
(RNA) and RNA interference (RNAi) therapeutics to treat diseases such as cancer and viral infections
like Ebola and Hepatitis B. RNAi involves the inhibition of gene expression through the destruction
of specific messenger RNA molecules. The company also licenses its delivery technology to partners
around the world.
--> Burnaby, BC
Titan Medical Inc.* (TSX is a recent graduate of TSXV that developed a robotic surgical system
that will allow surgeons to perform procedures such as gall bladder and appendix removal and ear,
nose and throat procedures. Currently, the most common medical procedures for which robotic
systems are used are hysterectomies and prostatectomies.
--> Toronto, ON
* Titan Medical Inc. graduated from TSXV to TSX on 30 September 2014.
Medical marijuana: New market, new opportunity
In 2014, the Canadian federal government began licensing companies in Canada to cultivate marijuana
for medical applications. It did not take long for three of these companies to start raising capital with
a listing on TSXV: Tweed Marijuana Inc. (TSXV , Bedrocan Cannabis Corp. (TSXV ) and
OrganiGram Inc. (TSXV . Investors who saw an opportunity in the new market could now buy
shares in each of these public companies as they developed and refined their medicinal products.
In order to list on TSXV, these companies must have already met the rigorous standards required to obtain
a government license, such as maintaining highly secure facilities, meeting strict standards for product
safety and cleanliness, and local community support. Through a public listing on TSXV, these companies
increased their level of openness and transparency which, in turn, helps build trust with stakeholders
including patients, doctors and investors.
“With the number of start-up companies in our industry, competition for capital is fierce,”
says Bruce Linton, Chief Executive Officer, Tweed Marijuana Inc. “[A listing on TSXV] enhances our
ability to raise capital as well as to reach a broad range of institutional and retail investors
who would otherwise be unable to invest. The more companies we see listed, the more
credibility we build as a sector. That’s good for Tweed, our patients and our shareholders.”